Cross-Sector entity
BMO Capital Markets is the most frequent co-covered peer, appearing in 2 of the 8 tracked stories. That works out to roughly 0.4 stories per week across a 154-day span. The busiest single day carried 2. earnings accounts for 3 of the 8 tracked stories, while 5 other categories carry the remainder.
8 verified stories tracked
Last mentioned: Aug 16, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 12 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
BMO Capital Markets is the most frequent co-covered peer, appearing in 2 of the 8 tracked stories. That works out to roughly 0.4 stories per week across a 154-day span. The busiest single day carried 2. earnings accounts for 3 of the 8 tracked stories, while 5 other categories carry the remainder. 13% of these stories carry negative sentiment. Wedbush appears in 8 tracked Cross-Sector stories published from March 16, 2026 through August 16, 2026. The tracked stories average 1.9 original sources each.
Computed from the 8 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Wedbush. Shared-story counts are live from our verified record — not editorial picks.
Earnings release
Replimune Group reported ($0.72) EPS, missing the ($0.69) Zacks consensus by $0.03. Stock opened at $14.97, down $0.22.
Insider sales
CEO Sushil Patel sold 39,341 shares at $12.97 and insider Konstantinos Xynos sold 11,447 shares at $12.97, both to cover tax withholding obligations.
Wedbush upgrade
Wedbush upgraded Replimune Group from neutral to outperform and set a $12.00 price target.
Leerink upgrade
Leerink Partners upgraded Replimune Group from market perform to outperform and raised its price target from $11.00 to $17.00.
Wells Fargo Price Target Raise and Tactical Ideas Addition
Wells Fargo raises PANW price target to $420 from $325, keeps Overweight rating, and adds the stock to its Q3 tactical ideas list with clear catalyst path.
Studios and Flagship Closure Announced
Reports confirm all Nike Studios have closed or suspended operations, and Nike shutters a flagship location amid broader store reductions.
BTIG Price Target Raise on PANW
BTIG raises its price target on Palo Alto Networks to $380 from $333, maintains Buy rating, and reiterates the stock as top pick.
WidePoint Contract Expansion
WidePoint announces its FedRAMP ITMS deployment is on schedule and receives $1 million in additional integration services from a leading U.S. telecom carrier.
BMO upgrade
BMO Capital Markets raised Replimune Group from underperform to outperform with a $16.00 price target.
Wall Street Zen upgrade
Wall Street Zen upgraded Replimune Group from strong sell to sell.
Jensen Huang Keynote
CEO Jensen Huang unveils the next generation of AI hardware and software services.
Wedbush $4T Outlook
Analyst firm Wedbush raises price targets, citing the 'once-in-a-decade' nature of the AI shift.
GTC 2026 Opening
Nvidia kicks off its annual developer conference with a focus on enterprise AI integration.
Nike Studios Debut
Nike partners with FitLab to open boutique fitness studios in Texas and California as part of experiential retail push.
Consumer Direct Acceleration Launched
Nike aggressively shifts away from wholesale partners to focus on own stores, digital, and exclusive product.
Replimune missed consensus EPS by $0.03 but held near its 52-week high at $14.97. Insider sales totaling over $650,000 were tax-related, while analyst targets now range up to $17, creating a gap between the $11.86 average target and the stock price.
Replimune reported ($0.72) EPS, missing by $0.03, but for biotech investors the quarter is a side note to pipeline catalysts and analyst upgrades. Insider sales were tax-related, and recent price targets of $16 to $17 suggest confidence in the oncolytic immunotherapy platform.
Source: tickerreport.com · themarketsdaily.com
EPAM Systems' Q3 EPS guidance of up to $3.46 topped consensus by 3.9%, while full-year profit view surged to $13.24, handily beating the $12.53 consensus. Despite a flat revenue outlook, the firm's improved profitability signals strong cost controls and could spark a re-rating of its discounted stock, now trading at 15.7x earnings.
Source: Ticker Report · Zolmax
Back-to-back price‑target increases from BTIG and Wells Fargo highlight a bullish narrative on Palo Alto Networks. With growth expectations anchored by AI demand and platform expansion, the stock is emerging as a top pick in a sector favored by hedge funds.
Analyst upgrades on Palo Alto Networks underscore a shift toward integrated security platforms that address AI-driven threats. The higher price targets reflect growing demand for solutions spanning identity, cloud, and endpoint security in an expanding attack landscape.
Source: insidermonkey.com
Nike has shut down all its Nike Studios boutique fitness locations and a flagship store, marking a sharp retreat from its direct-to-consumer acceleration strategy. Analysts label the 2020 DTC push a mistake that allowed competitors to gain ground, and the company is now rebuilding wholesale partnerships with retailers like Dick's Sporting Goods.
Source: Tom Nikic (us) · Tom Nikic (us)
Micron Technology shares are surging ahead of its quarterly earnings as a persistent global shortage of High Bandwidth Memory (HBM) bolsters the company's pricing power. Analysts have raised price targets to as high as $500, citing the critical role of Micron's HBM4 production in powering NVIDIA's next-generation AI architectures.
Source: fool.com · finance.yahoo.com
As Nvidia kicks off its GTC 2026 conference, market analysts are labeling the current valuation a 'once-in-a-decade' entry point. With expectations of a $4 trillion market cap outlook and new breakthroughs in AI inference, the stock is positioned as the primary beneficiary of the next wave of enterprise transformation.
